• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

嗅觉感知异常:对56例嗅觉倒错患者的系列分析。

Distorted odorant perception: analysis of a series of 56 patients with parosmia.

作者信息

Bonfils Pierre, Avan Paul, Faulcon Patrick, Malinvaud David

机构信息

ORL Research Laboratory and Department of Otorhinolaryngology-Head and Neck Surgery, Centre National de la Recherche Scientifique UPRESSA 7060, F-75105 Paris, France.

出版信息

Arch Otolaryngol Head Neck Surg. 2005 Feb;131(2):107-12. doi: 10.1001/archotol.131.2.107.

DOI:10.1001/archotol.131.2.107
PMID:15723940
Abstract

OBJECTIVE

To characterize the self-reported olfactory and gustatory symptoms, olfactory function, and causes in parosmia.

DESIGN

Assessment of olfactory symptoms and function in patients with a chief complaint of parosmia.

SETTING

A university hospital clinic and research facility.

PATIENTS

Fifty-six consecutive patients presented to the ORL Clinic, European Hospital Georges Pompidou, with a chief complaint of parosmia between October 2001 and November 2003.

MAIN OUTCOME MEASURES

Subjective olfactory symptom analysis and olfactory function test results.

RESULTS

The mean duration of parosmia was 63.0 months. Forty patients (71.4%) reported associated hyposmia and 16 (28.6%) reported anosmia. Olfactory testing revealed moderate to severe olfactory loss in all patients. Quantitative and qualitative alterations occurred simultaneously in 32 patients (57.1%); parosmia onset occurred within 3 months after quantitative dysosmia in 19 patients (33.9%) and after 3 months in 5 patients (8.9%). The sensation of parosmia was always unpleasant. The main odorant triggers eliciting parosmia are described. The mean severity of flavor dysfunction of the population, evaluated using a 10-cm visual analog scale, was 6.4. Thirty-one patients (55.4%) viewed their olfactory alteration as severely affecting their quality of life. The main clinical association of parosmia was upper respiratory tract infection, found in 42.8% of the patients. Others clinical associations are described.

CONCLUSION

The series of patients with parosmia presented herein, the largest in the literature, permits a clinical description of this rare olfactory abnormality.

摘要

目的

描述嗅觉倒错患者自我报告的嗅觉和味觉症状、嗅觉功能及病因。

设计

对以嗅觉倒错为主诉的患者进行嗅觉症状和功能评估。

地点

一家大学医院的诊所和研究机构。

患者

2001年10月至2003年11月期间,连续56例患者因嗅觉倒错为主诉就诊于欧洲乔治·蓬皮杜医院耳鼻喉科诊所。

主要观察指标

主观嗅觉症状分析和嗅觉功能测试结果。

结果

嗅觉倒错的平均持续时间为63.0个月。40例患者(71.4%)报告伴有嗅觉减退,16例(28.6%)报告嗅觉丧失。嗅觉测试显示所有患者均有中度至重度嗅觉减退。32例患者(57.1%)同时出现定量和定性改变;19例患者(33.9%)嗅觉倒错发作于定量嗅觉障碍后3个月内,5例患者(8.9%)发作于3个月后。嗅觉倒错的感觉总是不愉快的。描述了引发嗅觉倒错的主要气味触发因素。使用10厘米视觉模拟量表评估,该人群味觉功能障碍的平均严重程度为6.4。31例患者(55.4%)认为其嗅觉改变严重影响了他们的生活质量。嗅觉倒错的主要临床关联是上呼吸道感染,在42.8%的患者中发现。还描述了其他临床关联。

结论

本文介绍的嗅觉倒错患者系列是文献中最大的系列,允许对这种罕见的嗅觉异常进行临床描述。

相似文献

1
Distorted odorant perception: analysis of a series of 56 patients with parosmia.嗅觉感知异常:对56例嗅觉倒错患者的系列分析。
Arch Otolaryngol Head Neck Surg. 2005 Feb;131(2):107-12. doi: 10.1001/archotol.131.2.107.
2
Prognostic factors of olfactory dysfunction.嗅觉功能障碍的预后因素。
Arch Otolaryngol Head Neck Surg. 2010 Apr;136(4):347-51. doi: 10.1001/archoto.2010.27.
3
Patterns of non-conductive olfactory disorders in eastern Austria: a study of 120 patients from the Department of Otorhinolaryngology at the University of Vienna.奥地利东部非传导性嗅觉障碍模式:对维也纳大学耳鼻咽喉科120例患者的研究
Wien Klin Wochenschr. 2001 Jan 15;113(1-2):52-7.
4
[Signs and symptoms, etiologies and clinical course of parosmia + in a series of 84 patients].[84例嗅觉倒错患者的体征和症状、病因及临床病程]
Ann Otolaryngol Chir Cervicofac. 2000 Feb;117(1):12-8.
5
Post-infectious olfactory loss: a cohort study and update.感染后嗅觉丧失:一项队列研究及更新
B-ENT. 2009;5 Suppl 13:89-95.
6
Recovery of olfactory function following closed head injury or infections of the upper respiratory tract.闭合性颅脑损伤或上呼吸道感染后嗅觉功能的恢复。
Arch Otolaryngol Head Neck Surg. 2006 Mar;132(3):265-9. doi: 10.1001/archotol.132.3.265.
7
Lipoic acid in the treatment of smell dysfunction following viral infection of the upper respiratory tract.硫辛酸治疗上呼吸道病毒感染后嗅觉功能障碍
Laryngoscope. 2002 Nov;112(11):2076-80. doi: 10.1097/00005537-200211000-00031.
8
Prevalence of parosmia: the Skövde population-based studies.嗅觉倒错的患病率:基于舍夫德人群的研究
Rhinology. 2007 Mar;45(1):50-3.
9
Olfactory bulb volume in the clinical assessment of olfactory dysfunction.嗅觉功能障碍临床评估中的嗅球体积
Rhinology. 2009 Mar;47(1):3-9.
10
Epidemiological aspects of olfactory dysfunction.嗅觉功能障碍的流行病学方面
Rhinology. 2006 Mar;44(1):78-82.

引用本文的文献

1
Designing novel "Smell-Aids" to improve olfactory function in post COVID-19 era.设计新型“嗅觉辅助工具”以改善新冠疫情后时代的嗅觉功能。
BMC Med. 2025 Mar 24;23(1):169. doi: 10.1186/s12916-025-03999-y.
2
Parosmia: Pathophysiology and Management.嗅觉倒错:病理生理学与管理
Curr Allergy Asthma Rep. 2025 Jan 16;25(1):10. doi: 10.1007/s11882-024-01189-z.
3
Parosmia in patients with post-infectious olfactory dysfunction in the era of COVID-19-associated olfactory impairment.新冠病毒相关嗅觉障碍流行时期,感染后嗅觉障碍患者的嗅觉异常。
HNO. 2024 Sep;72(9):649-656. doi: 10.1007/s00106-024-01470-7. Epub 2024 Jun 27.
4
The effects of anxiety on taste perception: The role of awareness.焦虑对味觉感知的影响:意识的作用。
Iperception. 2023 Nov 23;14(6):20416695231216370. doi: 10.1177/20416695231216370. eCollection 2023 Nov-Dec.
5
A double-blinded randomised controlled trial of vitamin A drops to treat post-viral olfactory loss: study protocol for a proof-of-concept study for vitamin A nasal drops in post-viral olfactory loss (APOLLO).维生素A滴剂治疗病毒感染后嗅觉丧失的双盲随机对照试验:维生素A滴鼻剂治疗病毒感染后嗅觉丧失(APOLLO)概念验证研究的研究方案
Pilot Feasibility Stud. 2023 Oct 12;9(1):174. doi: 10.1186/s40814-023-01402-2.
6
What Is Different in COVID-19-Associated Olfactory Loss from Classical Postinfectious Olfactory Impairment?新型冠状病毒肺炎相关嗅觉丧失与经典感染后嗅觉障碍有何不同?
ORL J Otorhinolaryngol Relat Spec. 2023;85(5):245-247. doi: 10.1159/000533228. Epub 2023 Aug 17.
7
Proof-of-concept: SCENTinel 1.1 rapidly discriminates COVID-19-related olfactory disorders.概念验证:SCENTinel 1.1 快速区分与 COVID-19 相关的嗅觉障碍。
Chem Senses. 2023 Jan 1;48. doi: 10.1093/chemse/bjad002.
8
Postinfectious Olfactory Complaints: A Follow-up Study.感染后嗅觉问题:一项随访研究。
Int Arch Otorhinolaryngol. 2022 Mar 2;26(4):e657-e660. doi: 10.1055/s-0042-1742761. eCollection 2022 Oct.
9
Drug-Associated Parosmia: New Perspectives from the WHO Safety Database.药物相关性嗅觉倒错:来自世界卫生组织安全数据库的新视角
J Clin Med. 2022 Aug 9;11(16):4641. doi: 10.3390/jcm11164641.
10
Qualitative Olfactory Dysfunction and COVID-19: An Evidence-Based Review with Recommendations for the Clinician.定性嗅觉功能障碍与 COVID-19:基于证据的综述及对临床医生的建议。
Am J Rhinol Allergy. 2023 Jan;37(1):95-101. doi: 10.1177/19458924221120117. Epub 2022 Aug 11.